Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -51.09% is 10% above its 5-year average of -56.99%, near the high end of its 5-year range (-948.10%–24.85%).
As of the fiscal period ended Tuesday, June 30, 2026. 110.83% below its 12-month average of -24.23%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -51.09%.
RETURN ON EQUITY (ROE)
-51.09%
RETURN ON EQUITY (ROE) AVG TTM
-24.23%
RETURN ON EQUITY (ROE) AVG 3Y
-63.82%
RETURN ON EQUITY (ROE) AVG 5Y
-56.99%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-110.83%
CURRENT VS 3Y AVG
+19.95%
CURRENT VS 5Y AVG
+10.35%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-21.61%
vs the sector median at left
SkinHealth Systems Inc.
Market Cap
$75.95M
Return on Equity (ROE)
-51.09%
TTM Avg
-24.23%
3Y Avg
-63.82%
5Y Avg
-56.99%
Market Cap
$75.18M
Return on Equity (ROE)
-122.76%
TTM Avg
-82.75%
3Y Avg
-63.80%
5Y Avg
-49.10%
Market Cap
$76.74M
Return on Equity (ROE)
-77.12%
TTM Avg
-270.75%
3Y Avg
-187.09%
5Y Avg
-136.77%
Market Cap
$77.54M
Return on Equity (ROE)
N/A
TTM Avg
354.96%
3Y Avg
354.96%
5Y Avg
354.96%
Market Cap
$78.07M
Return on Equity (ROE)
-1542.57%
TTM Avg
-254.55%
3Y Avg
-187.52%
5Y Avg
-143.69%
Market Cap
$78.29M
Return on Equity (ROE)
-55.97%
TTM Avg
-55.58%
3Y Avg
-51.87%
5Y Avg
-151.31%
Market Cap
$78.59M
Return on Equity (ROE)
-6.05%
TTM Avg
-96.60%
3Y Avg
16.82%
5Y Avg
35.21%
Market Cap
$73.27M
Return on Equity (ROE)
-94.81%
TTM Avg
-84.90%
3Y Avg
-70.34%
5Y Avg
-58.48%
Market Cap
$79.03M
Return on Equity (ROE)
-114.06%
TTM Avg
-50.52%
3Y Avg
-45.18%
5Y Avg
-45.18%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | $75.95M | -51.09% | -24.23% | -63.82% | -56.99% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -122.76% | -82.75% | -63.80% | -49.10% |
| Outset Medical, Inc. (OM)vs › | $76.74M | -77.12% | -270.75% | -187.09% | -136.77% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | N/A | 354.96% | 354.96% | 354.96% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -1542.57% | -254.55% | -187.52% | -143.69% |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -55.97% | -55.58% | -51.87% | -151.31% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -6.05% | -96.60% | 16.82% | 35.21% |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | -94.81% | -84.90% | -70.34% | -58.48% |
| Citius Oncology, Inc. (CTOR)vs › | $79.03M | -114.06% | -50.52% | -45.18% | -45.18% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | -250.39% | -122.53% | -92.00% | -67.18% |
ROE
-51.1%
ROA
-5.8%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -51.09% |
| 2026-03-31 | -10.91% |
| 2025-12-31 | -15.59% |
| 2025-09-30 | -17.89% |
| 2025-06-30 | -25.68% |
| 2025-03-31 | -83.62% |
| 2024-12-31 | -56.17% |
| 2024-09-30 | -47.17% |
| 2024-06-30 | -120.97% |
| 2024-03-31 | -127.24% |
| 2023-12-31 | -168.57% |
| 2023-09-30 | -96.60% |
| 2023-06-30 | -8.13% |
| 2023-03-31 | -6.91% |
| 2022-12-31 | 24.85% |
| 2022-09-30 | 7.90% |
| 2022-06-30 | -55.26% |
| 2022-03-31 | -99.61% |
| 2021-12-31 | -124.09% |
| 2021-06-30 | -948.10% |
